Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2009:41–42. doi: 10.1007/978-1-60327-297-1_7

Virology

Vassil St Georgiev 2,✉
Editor: Vassil St Georgiev1
PMCID: PMC7121647

Abstract

NIAD supports a broad spectrum of both basic and applied research in virology to expand the understanding of the biology, pathogenesis, and the immunology of viral diseases, leading to their prevention, control, and treatment, including research on (i) the viral replication cycle; (ii) the structure and function of the viral components; (iii) host virus interactions, including pathogenesis, immune evasion, and immune enhancement; (iv) viral genetics and evolution; (v) viral interference and defective interfering particles; (vi) virus vector relationships; (vii) epidemiology and natural history; and (viii) preclinical and clinical research to develop vaccines, adjuvants, therapeutics, immunomodulators, and diagnostics (http://www3.niaid.nih.gov/research/topics/viral/introduction.)

Keywords: West Nile Virus, Severe Acute Respiratory Syndrome, Dengue Virus, Severe Acute Respiratory Syndrome, West Nile Virus Infection

Contributor Information

Vassil St. Georgiev, Email: vgeorgiev@niaid.nih.gov.

Vassil St. Georgiev, Email: vgeorgiev@niaid.nih.gov.

References

  • 1.Li Q., Ali M.A., Cohen J.I. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell. 2006;127(2):305–316. doi: 10.1016/j.cell.2006.08.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yin H.-S., Wen X., Paterson R.G., Lamb R.A., Jardetzky T.S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion confirmation. Nature. 2006;439:38–44. doi: 10.1038/nature04322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., Ebel G.D., Kramer L.D., Fremont D., H., Diamond M.S. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 2005;11:522–530. doi: 10.1038/nm1240. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from National Institute of Allergy and Infectious Diseases, NIH are provided here courtesy of Nature Publishing Group

RESOURCES